RESUMEN
Resumen Se presentan las recomendaciones en las cuales la Sociedad Mexicana de Cardiología (SMC) en conjunto con la Asociación Nacional de Cardiólogos de México (ANCAM), así como diferentes asociaciones médicas mexicanas vinculadas con la cardiología, después de una revisión y análisis exhaustivo y consensuado sobre los tópicos relacionados con las enfermedades cardiovasculares en la pandemia de COVID-19, se analizan posturas científicas y se dan recomendaciones responsables sobre medidas generales a los pacientes, con cuidados personales, alimentación saludable, actividad física regular, acciones en caso de paro cardiorrespiratorio, la protección del paciente y del personal de salud así como las indicaciones precisas en el uso de la imagen cardiovascular no invasiva, la prescripción de medicamentos, cuidados en tópicos específicos como en la hipertensión arterial sistémica, insuficiencia cardiaca, arritmias y síndromes coronarios agudos, además de hacer énfasis en los procedimientos de electrofisiología, intervencionismo, cirugía cardiaca y en la rehabilitación cardiaca. El interés principal es brindar a la comunidad médica una orientación general sobre el quehacer en la práctica cotidiana y pacientes con enfermedades cardiovasculares en el escenario esta crisis epidemiológica sin precedentes de COVID-19.
Abstract The recommendations in which the Mexican Society of Cardiology (SMC) in conjunction with the National Association of Cardiologists of Mexico (ANCAM) as well as different Mexican medical associations linked to cardiology are presented, after a comprehensive and consensual review and analysis of the topics related to cardiovascular diseases in the COVID-19 pandemic. Scientific positions are analyzed and responsible recommendations on general measures are given to patients, with personal care, healthy eating, regular physical activity, actions in case of cardio-respiratory arrest, protection of the patient and health personnel as well as precise indications in the use of non-invasive cardiovascular imaging, prescription of medications, care in specific topics such as systemic arterial hypertension, heart failure, arrhythmias and acute coronary syndromes, in addition to emphasizing electrophysiology, interventionism, cardiac surgery and in cardiac rehabilitation. The main interest is to provide the medical community with a general orientation on what to do in daily practice and patients with cardiovascular diseases in the setting of this unprecedented epidemiological crisis of COVID-19.
Asunto(s)
Humanos , Neumonía Viral/epidemiología , Cardiología , Enfermedades Cardiovasculares/terapia , Infecciones por Coronavirus/epidemiología , Sociedades Médicas , Enfermedades Cardiovasculares/fisiopatología , Enfermedades Cardiovasculares/virología , Pandemias , Rehabilitación Cardiaca/métodos , COVID-19 , Procedimientos Quirúrgicos Cardíacos/métodos , MéxicoRESUMEN
Se presenta el caso clínico de un paciente de 53 años que tras una intervención neuroquirúrgica (laminectomía) presentó cuadro séptico. Se identificó la presencia de S. lugdunensis en la herida operatoria. El ecocardiograma transesofágico demostró rotura valvular mitral, vegetaciones e insuficiencia mitral masiva. El paciente se recuperó satisfactoriamente tras reemplazo valvular por prótesis mecánica.
A 53 year old man developed sepsis following laminectomy for spinal disease. S lugdunensis was identified from the surgical wound. Trans esophageal echocardiography demonstrated mitral valve rupture, vegetations and severe mitral regurgitation. The patient successfully recovered following mitral valve replacement with a mechanical prosthesis.
Asunto(s)
Humanos , Masculino , Persona de Mediana Edad , Endocarditis Bacteriana/diagnóstico , Endocarditis Bacteriana/terapia , Infecciones Estafilocócicas/diagnóstico , Infecciones Estafilocócicas/terapia , Antibacterianos/uso terapéutico , Infección Hospitalaria , Implantación de Prótesis de Válvulas Cardíacas/métodos , Staphylococcus lugdunensis/aislamiento & purificación , Válvula Mitral/cirugía , Válvula Mitral/microbiologíaRESUMEN
OBJECTIVE: To assess the diagnostic value of a single determination of serum C-reactive protein as a marker of sepsis in critically ill patients. DESIGN: Prospective, observational study. SETTING: Intensive care unit of a university hospital. PATIENTS AND PARTICIPANTS: One hundred twenty-five adult patients with systemic inflammatory response syndrome (SIRS) (55 patients without evidence of infection and 70 patients with the diagnosis of sepsis confirmed by documented infection). Twenty-five patients with non-complicated acute myocardial infarctions (AMI) and 50 healthy volunteers were used as controls. INTERVENTIONS: None. MEASUREMENTS AND RESULTS: Serum C-reactive protein concentration was measured within the first 24 h of SIRS onset. Healthy subjects, AMI and non-infectious SIRS patients showed lower C-reactive protein median values ([(0.21 [95% confidence intervals (95% CI), 0.21-0.4] mg/dl, 2.2 [95% CI, 2.1-4.9] mg/dl and 1.7 [95% CI, 2.4-5.5] mg/dl, respectively) than patients with sepsis (18.9 [95% CI, 17.1-21.8]), p<0.001. The presence of severe sepsis ( r(s)=0.27; p=0.03), SOFA score ( r(s)=0.25; p=0.03) and arterial lactate ( r(s)=0.24; p=0.04) correlated significantly with C-reactive protein concentrations in sepsis cases. The best threshold value for C-reactive protein for predicting sepsis was 8 mg/dl (sensitivity 94.3%, specificity 87.3%). The area under the receiver-operating characteristic curve for C-reactive protein was 0.94 (95% CI, 0.89-0.98). CONCLUSIONS: Determination of serum C-reactive protein can be used as an early indicator of infection in patients with SIRS.
